Stock Report

Bafna Pharmaceuticals Ltd Q3FY23 profit climbs to Rs. 2.99 crore



Posted On : 2023-02-08 14:43:35( TIMEZONE : IST )

Bafna Pharmaceuticals Ltd Q3FY23 profit climbs to Rs. 2.99 crore

Bafna Pharmaceuticals Limited has reported Standalone financial results for the period ended December 31, 2022.

Financial Results (Q3 FY2023) - QoQ Comparison

The company has reported total income of Rs. 35.6311 crores during the period ended December 31, 2022 as compared to Rs. 22.6030 crores during the period ended September 30, 2022.

The company has posted net profit / (loss) of Rs. 2.9949 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 1.6089 crores for the period ended September 30, 2022.

The company has reported EPS of Rs. 1.26 for the period ended December 31, 2022 as compared to Rs. 0.68 for the period ended September 30, 2022.

Financials Q3 FY2023 Q2 FY2023 % Change
Total Income ₹35.6311 crs ₹22.6030 crs Up Tick / Down Tick57.64%
Net Profit ₹2.9949 crs ₹1.6089 crs Up Tick / Down Tick86.15%
EPS ₹1.26 ₹0.68 Up Tick / Down Tick85.29%

Financial Results (Q3 FY2023) - YoY Comparison

The company has reported total income of Rs.35.6311 crores during the period ended December 31, 2022 as compared to Rs.20.9474 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.2.9949 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.1.7029 crores for the period ended December 31, 2021.

The company has reported EPS of Rs.1.26 for the period ended December 31, 2022 as compared to Rs.0.72 for the period ended December 31, 2021.

Financials Q3 FY2023 Q3 FY2022 % Change
Total Income ₹35.6311 crs ₹20.9474 crs Up Tick / Down Tick70.10%
Net Profit ₹2.9949 crs ₹1.7029 crs Up Tick / Down Tick75.87%
EPS ₹1.26 ₹0.72 Up Tick / Down Tick75.00%

Financial Results (9 Months Ended FY2023) - YoY Comparison

The company has reported total income of Rs.76.4624 crores during the 9 Months period ended December 31, 2022 as compared to Rs.70.9916 crores during the 9 Months period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.5.9661 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.6.1660 crores for the 9 Months period ended December 31, 2021.

The company has reported EPS of Rs.2.51 for the 9 Months period ended December 31, 2022 as compared to Rs.2.55 for the 9 Months period ended December 31, 2021.

Financials 9 Months Ended FY2023 9 Months Ended FY2022 % Change
Total Income ₹76.4624 crs ₹70.9916 crs Up Tick / Down Tick7.71%
Net Profit ₹5.9661 crs ₹6.1660 crs Up Tick / Down Tick-3.24%
EPS ₹2.51 ₹2.55 Up Tick / Down Tick-1.57%

Shares of Bafna Pharmaceuticals Limited was last trading in BSE at Rs. 96.00 as compared to the previous close of Rs. 99.45. The total number of shares traded during the day was 242 in over 10 trades.

The stock hit an intraday high of Rs. 98.60 and intraday low of 94.55. The net turnover during the day was Rs. 23486.00.

Source : Equity Bulls

Keywords

BafnaPharmaceuticals Q3FY23 9MFY23 ResultUpdate